David Hesk

4.1k total citations · 2 hit papers
79 papers, 2.6k citations indexed

About

David Hesk is a scholar working on Molecular Biology, Pharmaceutical Science and Organic Chemistry. According to data from OpenAlex, David Hesk has authored 79 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 37 papers in Pharmaceutical Science and 18 papers in Organic Chemistry. Recurrent topics in David Hesk's work include Chemical Reactions and Isotopes (35 papers), Amino Acid Enzymes and Metabolism (11 papers) and Chemical Synthesis and Analysis (11 papers). David Hesk is often cited by papers focused on Chemical Reactions and Isotopes (35 papers), Amino Acid Enzymes and Metabolism (11 papers) and Chemical Synthesis and Analysis (11 papers). David Hesk collaborates with scholars based in United States, United Kingdom and Germany. David Hesk's co-authors include Nelo R. Rivera, Paul J. Chirik, Ian W. Davies, István Pelczer, Renyuan Pony Yu, Haifeng Yang, Steven L. Colletti, Kazunori Nagao, Andrew J. Hoover and David W. C. MacMillan and has published in prestigious journals such as Nature, Science and Journal of the American Chemical Society.

In The Last Decade

David Hesk

78 papers receiving 2.5k citations

Hit Papers

Photoredox-catalyzed deuteration and tritiation of pharma... 2016 2026 2019 2022 2017 2016 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Hesk United States 25 1.4k 841 835 698 259 79 2.6k
Tracey Pirali Italy 27 753 0.5× 2.8k 3.3× 432 0.5× 1.6k 2.3× 193 0.7× 67 4.2k
Stefanie Bendels Switzerland 14 1.2k 0.9× 1.3k 1.6× 290 0.3× 891 1.3× 285 1.1× 15 2.9k
Björn Wagner Switzerland 27 902 0.7× 1.8k 2.2× 282 0.3× 1.1k 1.5× 254 1.0× 50 2.9k
Kyle J. Eastman United States 8 2.1k 1.5× 2.4k 2.8× 624 0.7× 604 0.9× 107 0.4× 12 3.2k
Zhanni Gu China 10 2.3k 1.7× 2.2k 2.6× 700 0.8× 484 0.7× 133 0.5× 13 3.1k
Per I. Arvidsson Sweden 39 279 0.2× 3.2k 3.8× 563 0.7× 2.0k 2.9× 233 0.9× 140 4.6k
Shalini Andersson Sweden 29 311 0.2× 220 0.3× 271 0.3× 1.1k 1.6× 874 3.4× 68 2.5k
Hiroki Moriwaki Spain 29 966 0.7× 1.8k 2.1× 632 0.8× 1.3k 1.8× 297 1.1× 77 2.7k
Andrew Sutherland United Kingdom 30 418 0.3× 2.4k 2.9× 443 0.5× 1.6k 2.3× 145 0.6× 257 4.0k

Countries citing papers authored by David Hesk

Since Specialization
Citations

This map shows the geographic impact of David Hesk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Hesk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Hesk more than expected).

Fields of papers citing papers by David Hesk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Hesk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Hesk. The network helps show where David Hesk may publish in the future.

Co-authorship network of co-authors of David Hesk

This figure shows the co-authorship network connecting the top 25 collaborators of David Hesk. A scholar is included among the top collaborators of David Hesk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Hesk. David Hesk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Derdau, Volker & David Hesk. (2020). Hydrogen isotope exchange labelling: A brief update. Journal of Labelled Compounds and Radiopharmaceuticals. 63(6). 246–246. 1 indexed citations
2.
Hesk, David, David M. Lindsay, William J. Kerr, et al.. (2020). Synthesis of [3H] and [14C]genipin. Journal of Labelled Compounds and Radiopharmaceuticals. 63(4). 196–202. 2 indexed citations
3.
Yang, Haifeng & David Hesk. (2020). Base metal‐catalyzed hydrogen isotope exchange. Journal of Labelled Compounds and Radiopharmaceuticals. 63(6). 296–307. 50 indexed citations
4.
Musacchio, Patricia Z., Sumei Ren, Thomas J. A. Graham, et al.. (2020). Metallaphotoredox aryl and alkyl radiomethylation for PET ligand discovery. Nature. 589(7843). 542–547. 86 indexed citations
5.
Czeskis, Boris A., Charles S. Elmore, Anthony R. Haight, et al.. (2019). Deuterated active pharmaceutical ingredients: A science‐based proposal for synthesis, analysis, and control. Part 1: Framing the problem. Journal of Labelled Compounds and Radiopharmaceuticals. 62(11). 690–694. 21 indexed citations
6.
Ren, Sumei, Patrick S. Fier, Hong Ren, et al.. (2018). 34S: A New Opportunity for the Efficient Synthesis of Stable Isotope Labeled Compounds. Chemistry - A European Journal. 24(28). 7133–7136. 4 indexed citations
7.
Nagao, Kazunori, Andrew J. Hoover, David Hesk, et al.. (2017). Photoredox-catalyzed deuteration and tritiation of pharmaceutical compounds. Science. 358(6367). 1182–1187. 461 indexed citations breakdown →
8.
Wang, Hao, Marc Labroli, Christine Yang, et al.. (2016). Quantitation of wall teichoic acid in Staphylococcus aureus by direct measurement of monomeric units using LC-MS/MS. Analytical Biochemistry. 518. 9–15. 2 indexed citations
9.
Rivera, Nelo R., Sumei Ren, & David Hesk. (2015). Synthesis of a [14C]‐steroid intermediate: an application of a nonstabilized Horner–Wadsworth–Emmons olefination approach. Journal of Labelled Compounds and Radiopharmaceuticals. 58(1). 20–22. 5 indexed citations
10.
Demma, Mark J., Eugene Maxwell, Robert Ramos, et al.. (2010). SCH529074, a Small Molecule Activator of Mutant p53, Which Binds p53 DNA Binding Domain (DBD), Restores Growth-suppressive Function to Mutant p53 and Interrupts HDM2-mediated Ubiquitination of Wild Type p53. Journal of Biological Chemistry. 285(14). 10198–10212. 83 indexed citations
11.
Nomeir, Amin A., Richard A. Morrison, Walter A. Korfmacher, et al.. (2009). Estimation of the extent of oral absorption in animals from oral and intravenous pharmacokinetic data in drug discovery. Journal of Pharmaceutical Sciences. 98(11). 4027–4038. 9 indexed citations
12.
Chackalamannil, Samuel, Yan Xia, Keith Eagen, et al.. (2007). Heterotricyclic Himbacine Analogs as Potent, Orally Active Thrombin Receptor (Protease Activated Receptor-1) Antagonists. Journal of Medicinal Chemistry. 50(21). 5147–5160. 24 indexed citations
13.
Gonsiorek, Waldemar, David Hesk, Shu‐Cheng Chen, et al.. (2006). Characterization of Peripheral Human Cannabinoid Receptor (hCB2) Expression and Pharmacology Using a Novel Radioligand, [35S]Sch225336. Journal of Biological Chemistry. 281(38). 28143–28151. 20 indexed citations
14.
Hesk, David, et al.. (2006). A simple and efficient synthesis of [3α3H]5α‐androst‐16‐en‐3β‐ol. Journal of Labelled Compounds and Radiopharmaceuticals. 49(11). 959–963. 2 indexed citations
15.
Anthes, John C., Christian Richard, David Hesk, et al.. (2002). Biochemical characterization of desloratadine, a potent antagonist of the human histamine H1 receptor. European Journal of Pharmacology. 449(3). 229–237. 105 indexed citations
16.
Ahn, Ho-Sam, Carolyn Foster, George Boykow, et al.. (1997). Binding of a Thrombin Receptor Tethered Ligand Analogue to Human Platelet Thrombin Receptor. Molecular Pharmacology. 51(2). 350–356. 46 indexed citations
17.
Hesk, David, et al.. (1992). A Rapid Method for Isolating Glandular Trichomes. PLANT PHYSIOLOGY. 99(1). 1–7. 56 indexed citations
18.
Hesk, David, John R. Jones, & Steven W. Lockley. (1991). Regiospecific Deuteriation and Tritiation of Various Drugs Using a Homogeneous Rhodium Trichloride Catalyst. Journal of Pharmaceutical Sciences. 80(9). 887–890. 39 indexed citations
19.
Hesk, David, George Hildenbrandt, C. Channa Reddy, et al.. (1991). Inhibition of lipoxygenase and prostaglandin endoperoxide synthase by anacardic acids. Biochemical and Biophysical Research Communications. 176(2). 775–780. 62 indexed citations
20.
Hesk, David, D. H. Hutson, & C. J. Logan. (1988). The fate of 4-cyanoacetanilide in rats and mice; mechanism of formation of a novel electrophilic metabolite. Xenobiotica. 18(8). 955–966. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026